BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16208124)

  • 1. Does the patient with a positive fecal occult blood test, who at the same time is taking a nonsteroidal anti-inflammatory drug, require further evaluation to rule out a colorectal cancer?
    Babb RR
    J Clin Gastroenterol; 2005; 39(10):921. PubMed ID: 16208124
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer.
    Pye G; Ballantyne KC; Armitage NC; Hardcastle JD
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1510-1. PubMed ID: 3111616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients.
    Levin TR
    Am J Gastroenterol; 2009 Apr; 104(4):939-41. PubMed ID: 19293790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Lieberman N; Klang S; Niv Y
    Am J Gastroenterol; 2009 Apr; 104(4):933-8. PubMed ID: 19293792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of combining a immunological fecal occult blood test (latex method) with a chemical test (guaiac method)].
    Hamajima E; Asai T; Okumura S; Yamaguchi H; Katou T; Yamamoto Y; Kinoshita O
    Gan No Rinsho; 1990 Jan; 36(1):71-4. PubMed ID: 2299793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.
    Kahi CJ; Imperiale TF
    Am J Med; 2004 Dec; 117(11):837-41. PubMed ID: 15589487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood test performance indicators in warfarin-treated patients.
    Kershenbaum A; Lavi I; Rennert G; Almog R
    Dis Colon Rectum; 2010 Feb; 53(2):224-9. PubMed ID: 20087099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
    Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
    Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult GI bleeding in NSAID users--the base of the iceberg!
    McCarthy DM
    Clin Gastroenterol Hepatol; 2005 Nov; 3(11):1071-4. PubMed ID: 16271336
    [No Abstract]   [Full Text] [Related]  

  • 11. Biliary excretion of radiochromium.
    De Médicis R; LeBel E; Rioux A; Navert H; Lamoureux G; Tetreault L; Lussier A
    Am J Med; 1988 Aug; 85(2):276. PubMed ID: 3261133
    [No Abstract]   [Full Text] [Related]  

  • 12. The findings and impact of nonrehydrated guaiac examination of the rectum (FINGER) study: a comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients.
    Bini EJ; Rajapaksa RC; Weinshel EH
    Arch Intern Med; 1999 Sep; 159(17):2022-6. PubMed ID: 10510987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin use and performance of immunochemical fecal occult blood tests.
    Brenner H; Tao S; Haug U
    JAMA; 2010 Dec; 304(22):2513-20. PubMed ID: 21139112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening.
    Clarke P; Jack F; Carey FA; Steele RJ
    Colorectal Dis; 2006 Jun; 8(5):389-92. PubMed ID: 16684082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience in the diagnosis and therapy of upper digestive hemorrhage caused by nonsteroidal anti-inflammatory drugs].
    Capezzuto E; Carlini M; De Santis G
    Minerva Chir; 1987 Feb; 42(4):343-5. PubMed ID: 3495749
    [No Abstract]   [Full Text] [Related]  

  • 16. GI bleeding associated with nabumetone.
    Voss GD; Schweitzer P
    Am J Hosp Pharm; 1994 Oct; 51(19):2506, 2508. PubMed ID: 7847412
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.
    Hunt RH; Bowen B; Mortensen ER; Simon TJ; James C; Cagliola A; Quan H; Bolognese JA
    Am J Med; 2000 Aug; 109(3):201-6. PubMed ID: 10974182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonsteroidal anti-inflammatory agents and gastrointestinal pathology].
    Lanas AI
    Gastroenterol Hepatol; 1995 Mar; 18(3):142-52. PubMed ID: 7621292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ulcers of the colon in association with nonsteroidal anti-inflammatory drugs (NSAID)--a rare cause of gastrointestinal bleeding? Report of 3 cases].
    Schwake L; Schlenker T; Schwake S; Hofmann WJ; Stremmel W
    Z Gastroenterol; 2000 Dec; 38(12):957-61. PubMed ID: 11194886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the sensitivity of fecal occult blood test screening for colorectal cancer.
    Lang CA; Ransohoff DF
    J Natl Cancer Inst; 1997 Oct; 89(19):1392-3. PubMed ID: 9326904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.